Biomed Lublin, PLBMDLB00018

Synthaverse stock reports stronger revenue and EBITDA

Published on 10/08/2026 at 09:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Synthaverse stock posted PLN 26.461 million in H1 revenue on September 30, 2026, up 34.2 percent year over year. EBITDA reached PLN 5.415 million.

Biomed Lublin, PLBMDLB00018, Illustration mit AI erstellt.
Biomed Lublin, PLBMDLB00018, Illustration mit AI erstellt.

Synthaverse (ISIN PLBMDLB00018) reported PLN 26.461 million in net sales for the first half of 2026, a 34.2 percent increase from PLN 19.713 million in the same period of 2025. The September 30 report also showed EBITDA of PLN 5.415 million, up from PLN 2.239 million, giving Synthaverse stock a fresh operating milestone to weigh against continued losses.

Revenue growth meets deeper losses

According to Parkiet, the company reported a net loss of PLN 6.366 million for H1 2026, compared with a PLN 5.305 million loss in H1 2025. The result means sales and EBITDA improved together, while the bottom line moved in the opposite direction.

The same report put operating cash flow at PLN 6.819 million for the six months ended June 30, 2026, down from PLN 12.379 million a year earlier. Diluted loss per share was PLN 0.08, compared with PLN 0.07 in H1 2025, according to Parkiet.

Operating progress faces balance sheet pressure

The H1 figures create a divided investment picture. EBITDA improved by PLN 3.176 million year over year, while the net loss widened by PLN 1.061 million, so the key question is whether operating improvement can translate into earnings after financing and other costs.

At June 30, 2026, Synthaverse reported total assets of PLN 295.326 million, liabilities and provisions of PLN 176.455 million, and equity of PLN 118.872 million. Those figures place the operating recovery alongside a balance sheet that still requires close attention.

Stock trades at PLN 2.86

Synthaverse stock was trading at PLN 2.86 on the GPW on October 8, 2026, at 9:24 a.m. CEST, up 0.70 percent from the prior close of PLN 2.84. The same session showed a PLN 2.84 low and PLN 2.86 high, while the 52-week range stood at PLN 2.60 to PLN 4.34.

Synthaverse stock facts

  • Company: Synthaverse S.A.
  • ISIN: PLBMDLB00018
  • Ticker: SNTVERSE
  • Trading venue: GPW Main Market
  • Price (as of October 8, 2026, 9:24 a.m. CEST): PLN 2.86
  • Market capitalization: PLN 217.4 million (as of October 8, 2026)
  • 52-week range: PLN 2.60-4.34 (as of October 8, 2026)
  • Sector / Industry: Pharmaceuticals

Upcoming dates for Synthaverse stock

  • December 2, 2026: next earnings report

More news and analyses on Synthaverse stock

Disclaimer...

en | PLBMDLB00018 | BIOMED LUBLIN | boerse | 70263463 | bgmi